Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

NCT01282697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Refractory Solid Tumors in Children

Interventions

DRUG: Combined administration of irinotecan and rapamycin

Sponsor

University Hospital, Strasbourg, France

Collaborators

[object Object]